Schizophreniform Disorder
📧 Sign up to get email alerts when something new happens for Schizophreniform Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
This update reports results from a youth-focused trial evaluating the effectiveness and tolerability of a second-generation antipsychotic ac…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy [NA]
This entry reports the completion of a clinical trial evaluating the impact of cognitive-behavioral therapy on recovery from psychosis in in…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects [Phase 2]
Phase 2 clinical trial evaluating olanzapine in combination with zonisamide sustained-release to prevent weight gain in patients with schizo…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia [Phase 4]
Phase 4 trial evaluating ramelteon as an adjunct therapy in non-diabetic patients with schizophrenia and related disorders; results have bee…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Schizophrenic Patients in Integrated Care [Phase 4]
Phase 4 clinical trial sponsored by AstraZeneca evaluating schizophrenia-related conditions was terminated, with results posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl [Phase 1]
This completed Phase 1 pharmacokinetic study investigates how calorie intake and fat content influence the absorption and exposure of lurasi…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder [Phase 1]
This Phase 1 safety and pharmacokinetic study evaluated the extended-release osmotic-release (ER OROS) formulation of paliperidone in pediat…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients
The trial evaluated the safety and effectiveness of risperidone for acute psychosis in patients with schizophrenia or related disorders. The…
-
CLINICAL_TRIALS research · 2011-05-19Clinical Trial Update: PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders
Completed epidemiologic survey (PROFILe3) sponsored by Janssen-Cilag, evaluating patients with schizophrenia or schizoaffective disorders.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia
A terminated clinical trial evaluated the safety of risperidone in obese or overweight patients with schizophrenia or schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Study of Amantadine for Weight Stabilization During Olanzapine Treatment [Phase 1]
A Phase 1 study evaluating whether amantadine can stabilize weight during olanzapine treatment has been completed.
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [Phase 2, Phase 3]
An update on Phase 2 and Phase 3 trials evaluating whether omega-3 fatty acid EPA, combined with antioxidants, can treat schizophrenia and r…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia [Phase 4]
Phase 4 trial evaluating pregnenolone augmentation in patients with recent-onset schizophrenia; the study status is completed, but no result…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Schizophrenic Patients Taking Part in Integrated Care Program
The AstraZeneca-sponsored clinical trial involving schizophrenia and related psychotic disorders has been terminated.
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
A completed AstraZeneca-sponsored trial evaluated the validity of the Spanish version of the Subjective Well-being Under Neuroleptics Scale …
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. [Phase 4]
This update notes the completion of an open-label Phase 4 trial evaluating metformin for weight control in pediatric patients on antipsychot…
-
CLINICAL_TRIALS research · 2010-01-25Clinical Trial Update: A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia
A German multicenter clinical trial investigates the association between Toxoplasma gondii infection and first-episode schizophrenia. The up…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia [Phase 4]
Phase 4 clinical trial update on early onset antipsychotic drug action in schizophrenia and related disorders; results have been posted.
-
CLINICAL_TRIALS research · 2009-04-23Clinical Trial Update: Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment
This completed clinical trial from UMC Utrecht investigated functional brain activation patterns in individuals with schizophrenia before an…
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia [NA]
A completed clinical trial update evaluating neural inhibition as a mechanism of nicotine dependence in people with schizophrenia and relate…
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis [Phase 2]
A Phase 2 pilot study evaluating a modified cognitive behavioral therapy approach for adolescents with early onset psychosis.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Donepezil Double Blind Trial for ECT Memory Disfunction [Phase 4]
Phase 4 clinical trial update on a double-blind study of donepezil for memory dysfunction after electroconvulsive therapy in schizophrenia, …
-
CLINICAL_TRIALS research · 2008-11-11Clinical Trial Update: Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
This clinical trial update examines plasma levels of glutamatergic amino acids and oxytocin before and after neuroleptic treatment in patien…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study [Phase 2]
A Phase 2 pilot study evaluating selective estrogen receptor modulators for schizophrenia and related psychotic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-13Clinical Trial Update: Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic
This clinical trial update tracks service use and outcomes for a clinic serving first-episode psychosis and related psychotic disorders. The…